Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20. (Q39912811)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20. |
scientific article |
Statements
1 reference
Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20. (English)
1 reference
1 reference
David Daydé
1 reference
David Ternant
1 reference
Marc Ohresser
1 reference
Stéphanie Lerondel
1 reference
Sabrina Pesnel
1 reference
Hervé Watier
1 reference
Alain Le Pape
1 reference
Pierre Bardos
1 reference
Gilles Paintaud
1 reference
24 November 2008
1 reference
3765-3772
1 reference
Identifiers
1 reference